Does ISATUXIMAB Cause Malignant neoplasm progression? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Malignant neoplasm progression have been filed in association with ISATUXIMAB (Sarclisa). This represents 0.5% of all adverse event reports for ISATUXIMAB.
19
Reports of Malignant neoplasm progression with ISATUXIMAB
0.5%
of all ISATUXIMAB reports
4
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ISATUXIMAB?
Of the 19 reports, 4 (21.1%) resulted in death, 7 (36.8%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISATUXIMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ISATUXIMAB Cause?
Neutropenia (396)
Pneumonia (304)
Covid-19 (248)
Plasma cell myeloma (241)
Thrombocytopenia (227)
Infusion related reaction (213)
Pyrexia (202)
Anaemia (197)
Diarrhoea (162)
Off label use (126)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ISATUXIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
ISATUXIMAB vs ISATUXIMAB-IRFC
ISATUXIMAB vs ISAVUCONAZOLE
ISATUXIMAB vs ISAVUCONAZONIUM
ISATUXIMAB vs ISCALIMAB
ISATUXIMAB vs ISENTRESS